Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma

Seminars in Plastic Surgery 2019; 33: 270-278 DOI: 10.1055/s-0039-1696998Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an emerging and indolent, but potentially fatal cancer of the immune system that can develop around textured-surface breast implants. The World Health Organization first recognized BIA-ALCL as a unique clinical entity in 2016. To date, over 600 confirmed cases have been reported worldwide. BIA-ALCL most commonly presents with disease confined to the capsule, as a seroma or a mass adjacent to the implant. While BIA-ALCL has a fairly indolent clinical course, with an excellent prognosis in early stage disease, disseminated cancer and death have also been reported. In this review, the authors focus on the early diagnosis and treatment, including reconstructing the breast following BIA-ALCL, and also discuss recently updated National Comprehensive Cancer Network guidelines. They also review the current epidemiology and risk factors associated with BIA-ALCL. Finally, they discuss important medicolegal considerations and the bioethics surrounding the continued use of textured-surface breast implants. [...] Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Article in Thieme eJournals: Table of contents  |  Abstract  |  Full text
Source: Seminars in Plastic Surgery - Category: Cosmetic Surgery Authors: Tags: Review Article Source Type: research

Related Links:

Dr. Hamori recently addressed concerns over BIA-ALCL in this video." ALCL (Anaplastic large cell lymphoma) is a very rare disease, found in approximately one in 30,000 patients. So, while there is a lot of hype about it right now, and while I think it is important that women are aware of it, it is also creating a lot of panic for a disease that is quite uncommon.First of all, it affects only people who have textured implants — implants that have a little pebbling on the outside. The theory is that after seven or eight years contamination can occur, some over reactive immune response occurs, a fluid film for...
Source: What's New In Plastic Surgery? - Category: Cosmetic Surgery Tags: bia-alcl breast implant disease Source Type: blogs
We report a case of breast implant-associated anaplastic large cell lymphoma in a 70-year old woman, who 21 years previously had undergone bilateral breast augmentation with textured silicone implants. Eleven years later, she had bilateral implant removal with possible implant leak and presence of ‘atypical cells’ in the seroma. She then opted for prophylactic bilateral mastectomy in view of her strong family history of breast cancer and underwent reconstruction with subcutaneous gel implants. Eight months later, the patient noted right breast swelling and peri-implant effusion. The cytology was suspicious fo...
Source: Human Pathology: Case Reports - Category: Pathology Source Type: research
Two German companies have paired up on the development of a technology that could disrupt the breast implant market. BellaSeno will use Evonik's Resomer bioresorbable polymer in its Senella breast scaffolds with a proprietary additive manufacturing process that avoids the use of silicone implants, some of which have raised major safety concerns. BellaSeno plans to begin first-in-human clinical trials of the Senella scaffolds with Resomer in Germany this quarter. Evonik has agreed to supply its Resomer polymer for clinical and commercial use. The scaffolds are designed to guide the growth of natural tissue using the patient...
Source: MDDI - Category: Medical Devices Authors: Tags: 3-D Printing Source Type: news
AbstractPurpose of ReviewThe US Food and Drug Administration issued a recall of textured breast implants in July 2019 secondary to their association with anaplastic large cell lymphoma. This brief review serves to summarize what is actually known about breast implant associated anaplastic large cell lymphoma.Recent FindingsSince the FDA ’s first preliminary report in 2011, there have been a reported worldwide total of 573 breast implant associated anaplastic large cell lymphoma (BIA-ALCL) cases, including 33 deaths. In addition to halting the implantation of textured implants, the July recall served to increase aware...
Source: Current Breast Cancer Reports - Category: Cancer & Oncology Source Type: research
(CNN) — The US Food and Drug Administration on Wednesday released draft guidance recommending a “boxed warning” on labeling materials for breast implants. Boxed warnings, which alert health care providers and consumers to serious risks associated with a drug or device, are the strongest form of warning required by the FDA for labeling. An example of the boxed warning states that “breast implants are not considered lifetime devices” and “breast implants have been associated with the development of a cancer of the immune system called breast implant-associated anaplastic large cell lymphom...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News Syndicated CBSN Boston breast implant illness CNN Source Type: news
Irene Kennedy, 49, from Leeds, found out she had breast implant-associated anaplastic large cell lymphoma in January. The cancer is linked to 'textured' silicone breast implants.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Linzy Bromfield, 50, (pictured) 'thought she was going to die' after she developed implant-associated lymphoma in 2016. She had the implants put in at a private clinic in the UK in 2005.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
A major producer of breast implants is stopping the sale and distribution of their textured products, amid growing links to a rare and deadly cancer. The FDA requested the recall from Allergan after a "significant increase" in cases of a particular lymphoma. The FDA says the risk of lymphoma with Allergan's Biocell textured implants is approximately six times that of other manufacturers who are marketing in the U.S. Anna Werner reports.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
A major producer of breast implants is stopping the sale and distribution of their textured products, amid growing links to a rare and deadly cancer. The FDA requested the recall from Allergan after a "significant increase" in cases of a particular lymphoma. The FDA says the risk of lymphoma with Allergan's Biocell textured implants is approximately six times that of other manufacturers who are marketing in the U.S. Anna Werner reports.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
The FDA says the textured surface, unique to Allergan’s implants, are tied to 481 cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a type of non-Hodgkin’s lymphoma.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Breast Augmentation | Cancer | Cancer & Oncology | Epidemiology | International Medicine & Public Health | Lymphoma | Plastic Surgery | WHO